BLCM Overview
Upcoming Projects (BLCM)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BLCM)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (BLCM)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BLCM)
-
Bellicum Pharma (BLCM) to Present Preclinical Data on CAR-NK Cell Program at SITC 2019
Ticker: BLCM
Occurred on: Nov 08, 2019 -
Phase 1 initial data of Bellicum's(BLCM) BPX-601 Pancreatic cancer due at ASCO June 1, 2019, 8am CT
Ticker: BLCM
Occurred on: Jun 01, 2019 -
Bellicum Pharma (BLCM) to Complete Phase 1 Study of BPX-501 Following TCR Alpha Beta Depleted Stem Cell Transplant in December 2017
Ticker: BLCM
Occurred on: Nov 01, 2017 -
Bellicum Pharma (BLCM) to Complete Phase 1/2 study of BPX-501 Following a Partially Mismatched Stem Cell Transplant in January 2017
Ticker: BLCM
Occurred on: Jun 23, 2017 -
Bellicum (BLCM) Phase 1 BP-004 Data Evaluating BPX-501 and Rimiducid in Pediatric Patients After Hematopoietic Stem Cell Transplant
Ticker: BLCM
Occurred on: Feb 23, 2017 -
Bellicum Pharma (BLCM) to initiate Phase 1 trial of BPX-701 in patients with metastatic uveal melanoma in late 2016
Ticker: BLCM
Occurred on: Nov 09, 2016 -
Bellicum Pharma (BLCM) to expand US manufacturing capabilities by end of 2016
Ticker: BLCM
Occurred on: Nov 09, 2016 -
Bellicum Pharma (BLCM) to initiate enrollment in Phase 1 trial of BPX-601 in patients with non-resectable pancreatic cancer in mid 2016
Ticker: BLCM
Occurred on: Aug 08, 2016 -
Bellicum Pharma (BLCM) to update interim BPX-501 data at European Society for Blood and Marrow Transplantation
Ticker: BLCM
Occurred on: Apr 05, 2016
Strategic Initiatives (BLCM)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
